
AVAH Stock Forecast & Price Target
AVAH Analyst Ratings
Bulls say
Aveanna Healthcare Holdings Inc. reported a revenue rate of $495.43, reflecting a slight increase of 0.6%, alongside an improved gross margin of 32.6%, which surpassed expectations due to better-than-anticipated brand and regional administrative costs. The company demonstrated substantial growth in its Private Duty Services and Home Health & Hospice segments, with PDS revenue at $514.4 million, marking a remarkable 25.6% year-on-year increase, and HHH revenue reaching $62.4 million, a 15.3% growth compared to the previous year. Additionally, Aveanna's cash flow performance improved, enhancing its financial flexibility, as management raised revenue guidance to over $2.375 billion, signaling confidence in continued growth driven by operational execution and strategic integration efforts.
Bears say
Aveanna Healthcare Holdings Inc faces numerous challenges that contribute to a negative outlook. Key concerns include potential reimbursement pressures, high leverage, and an inability to effectively integrate acquisitions, which could hinder growth and profitability. Additionally, projected labor headwinds may lead to a significant downside in adjusted EBITDA estimates for FY26, and there are ongoing risks related to regulatory issues and increasing competition in the healthcare market.
This aggregate rating is based on analysts' research of Aveanna Healthcare Holdings and is not a guaranteed prediction by Public.com or investment advice.
AVAH Analyst Forecast & Price Prediction
Start investing in AVAH
Order type
Buy in
Order amount
Est. shares
0 shares